PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Non Hodgkin Lymphoma
Interventions: DRUG: Enalapril
Sponsor: South Tees Hospitals NHS Foundation Trust
Collaborators: Newcastle University|University of Durham|Newcastle-upon-Tyne Hospitals NHS Trust